The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125311012 12531101 2 F 2007 20160711 20160706 20160719 EXP US-JAZZ-2016-US-012101 JAZZ 0.00 F Y 0.00000 20160719 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125311012 12531101 1 PS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID U 21196 4.5 G ORAL SOLUTION
125311012 12531101 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS U 21196 ORAL SOLUTION
125311012 12531101 3 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID U 21196 4.5 G ORAL SOLUTION
125311012 12531101 4 SS ZANAFLEX TIZANIDINE HYDROCHLORIDE 1 UNK 0
125311012 12531101 5 SS ADVIL IBUPROFEN 1 UNK 0
125311012 12531101 6 C ASPIRIN. ASPIRIN 1 UNK U 0 CHEWABLE TABLET
125311012 12531101 7 C VALTREX VALACYCLOVIR HYDROCHLORIDE 1 UNK U 0
125311012 12531101 8 C ALEVE NAPROXEN SODIUM 1 UNK U 0
125311012 12531101 9 C Calcium + d3 CALCIUMCHOLECALCIFEROL 1 U 0
125311012 12531101 10 C CLONAZEPAM. CLONAZEPAM 1 U 0
125311012 12531101 11 C CRESTOR ROSUVASTATIN CALCIUM 1 U 0 TABLET
125311012 12531101 12 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 U 0 CAPSULE
125311012 12531101 13 C LEVOXYL LEVOTHYROXINE SODIUM 1 U 0 TABLET
125311012 12531101 14 C PREVACID LANSOPRAZOLE 1 UNK U 0
125311012 12531101 15 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125311012 12531101 1 Fibromyalgia
125311012 12531101 4 Product used for unknown indication
125311012 12531101 5 Product used for unknown indication
125311012 12531101 6 Product used for unknown indication
125311012 12531101 7 Product used for unknown indication
125311012 12531101 8 Product used for unknown indication
125311012 12531101 9 Product used for unknown indication
125311012 12531101 10 Product used for unknown indication
125311012 12531101 11 Product used for unknown indication
125311012 12531101 12 Product used for unknown indication
125311012 12531101 13 Product used for unknown indication
125311012 12531101 14 Product used for unknown indication
125311012 12531101 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125311012 12531101 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125311012 12531101 Asthenia
125311012 12531101 Drug ineffective
125311012 12531101 Feeling abnormal
125311012 12531101 Glucose tolerance impaired
125311012 12531101 Nausea
125311012 12531101 Somnolence
125311012 12531101 Thyroidectomy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125311012 12531101 1 200607 201012 0
125311012 12531101 2 201012 201112 0
125311012 12531101 3 201112 0
125311012 12531101 4 201606 0
125311012 12531101 5 201606 0
125311012 12531101 6 20160201 0
125311012 12531101 7 20160101 0
125311012 12531101 8 20130101 0
125311012 12531101 14 201606 0
125311012 12531101 15 201606 0